Oncology CRO - Committed to Curing Cancer

The Global Oncology CRO of Choice

In the past 5 years:

  • 230+Projects
  • 50+Indications
  • 2,200+Sites
  • 11,600+Patients

At Synteract, we are focused on addressing the needs of emerging biotech companies. From recruiting patients with specific biomarkers and genetic characteristics to navigating complex logistics and timing with individualized therapies and addressing evolving trial designs—we accept the challenges that oncology clinical trials present.

In the past 5 years alone, we have managed 230+ oncology projects, with the greatest percentage of those in complex, challenging areas such as pathway-targeted therapies, chemotherapy, and immunotherapy, as well as cell-based therapies and gene therapies.

Our in-depth oncology trial knowledge spans the entire clinical process, from design and execution of proof-of-concept trials to submissions and regulatory approval.

  • We were one of the first CROs that began working in the innovative immunotherapy clinical development area over 10 years ago.
  • We have first-hand experience and specialized expertise in precision medicine trials matched to specific patient biomarkers and personalized treatments customized to the individual.
  • Greater than 85 percent of our project management team has oncology experience.

As a biotech specialized CRO operating in a highly-dynamic and evolving precision medicine cancer research landscape, we bring our longstanding oncology acumen to bear. The strong relationships we’ve developed with oncology investigative sites support your mission to advance treatments in this critical area of research. Learn about our experience navigating rare cancer and complex immunotherapy clinical trials.

    Learn more about how we bring your Oncology clinical trials to life!

    Contact Us
    x

    Submit RFI / RFP

    By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

    Required

    x

    Contact Synteract

    Tell us how to stay in touch with you:

    By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

    Required

    x

    Synteract Oncology Clinical Trial Leadership

    Christopher HeckmanContact us to find out more about our Oncology expertise and experience Red Arrow

    Christopher Heckman
    VP Oncology Development

    With 23 years of clinical research experience, Christopher Heckman is a visionary leader with management, clinical and business development experience. He possesses a broad experience base across the drug development lifecycle, with both strategic and operational lines of responsibility, with hands-on engagement in all development phases as well as global registration experience. Previously, he has held executive director positions at both Celerion and PPD, and was senior director for portfolio management with Parexel International.

    Contact us to find out more about our Oncology expertise and experience Red Arrow
    x

     

    x

     

    x

     

    x

    Download Resource

    By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

    *Required

    x

    To complete your download, please choose an option in the Internet Explorer pop-up window at the bottom of this browser.

    x

    Download Resource

    By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

    *Required

    x

    To complete your download, please choose an option in the Internet Explorer pop-up window at the bottom of this browser.

    x

    Opt In

    By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

    *Required